ZIM Laboratories Limited (NSE:ZIMLAB)
113.09
+0.69 (0.61%)
Jun 24, 2025, 1:29 PM IST
ZIM Laboratories Revenue
In the fiscal year ending March 31, 2025, ZIM Laboratories had annual revenue of 3.79B INR with 3.16% growth. ZIM Laboratories had revenue of 1.09B in the quarter ending March 31, 2025, a decrease of -7.73%.
Revenue
3.79B
Revenue Growth
+3.16%
P/S Ratio
1.42
Revenue / Employee
6.57M
Employees
577
Market Cap
5.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 3.79B | 116.16M | 3.16% |
Mar 31, 2024 | 3.68B | -310.92M | -7.80% |
Mar 31, 2023 | 3.99B | 651.00M | 19.52% |
Mar 31, 2022 | 3.34B | 261.64M | 8.51% |
Mar 31, 2021 | 3.07B | 295.19M | 10.63% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 272.67B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Mankind Pharma | 122.07B |
Aurobindo Pharma | 317.24B |
Fortis Healthcare | 77.83B |